UA105855U - METHOD OF TREATMENT OF REFERUSION DAMAGES OF THE HEART MUSCLE IN MYOCARDIAL INFARCTION - Google Patents

METHOD OF TREATMENT OF REFERUSION DAMAGES OF THE HEART MUSCLE IN MYOCARDIAL INFARCTION

Info

Publication number
UA105855U
UA105855U UAU201508869U UAU201508869U UA105855U UA 105855 U UA105855 U UA 105855U UA U201508869 U UAU201508869 U UA U201508869U UA U201508869 U UAU201508869 U UA U201508869U UA 105855 U UA105855 U UA 105855U
Authority
UA
Ukraine
Prior art keywords
heart muscle
coronary
myocardial infarction
referusion
damages
Prior art date
Application number
UAU201508869U
Other languages
Ukrainian (uk)
Inventor
Валентин Олександрович Шумаков
Борис Михайлович Тодуров
Олександр Валентинович Шумаков
Віктор Васильович Братусь
Original Assignee
Валентин Олександрович Шумаков
Борис Михайлович Тодуров
Олександр Валентинович Шумаков
Віктор Васильович Братусь
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Валентин Олександрович Шумаков, Борис Михайлович Тодуров, Олександр Валентинович Шумаков, Віктор Васильович Братусь filed Critical Валентин Олександрович Шумаков
Priority to UAU201508869U priority Critical patent/UA105855U/en
Publication of UA105855U publication Critical patent/UA105855U/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Спосіб лікування реперфузійних пошкоджень серцевого м'яза при інфаркті міокарда. За допомогою інструментальних методів визначають зону пошкодження серцевого м'яза і відповідно коронарну інфаркт-відповідальну артерію, після чого проводять коронарографію інфаркт-невідповідальної коронарної артерії з одночасним струминним введенням в неї кортикостероїдного препарату в ефективній терапевтичній дозі. Потім здійснюють інвазійне втручання в коронарну інфаркт-відповідальну артерію з наступним введенням в неї кортикостероїдного препарату в ефективній терапевтичній дозі.A method of treating reperfusion damage to the heart muscle in myocardial infarction. With the help of instrumental methods, the area of damage of the heart muscle and, accordingly, the coronary infarction-responsible artery is determined, after which a coronary angiography is performed with a coronary artery with simultaneous fluid injection of a corticosteroid drug into it at an effective therapeutic dose. Then invasive intervention in the coronary infarction-responsible artery is carried out, followed by the introduction of a corticosteroid drug into it at an effective therapeutic dose.

UAU201508869U 2015-09-15 2015-09-15 METHOD OF TREATMENT OF REFERUSION DAMAGES OF THE HEART MUSCLE IN MYOCARDIAL INFARCTION UA105855U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201508869U UA105855U (en) 2015-09-15 2015-09-15 METHOD OF TREATMENT OF REFERUSION DAMAGES OF THE HEART MUSCLE IN MYOCARDIAL INFARCTION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201508869U UA105855U (en) 2015-09-15 2015-09-15 METHOD OF TREATMENT OF REFERUSION DAMAGES OF THE HEART MUSCLE IN MYOCARDIAL INFARCTION

Publications (1)

Publication Number Publication Date
UA105855U true UA105855U (en) 2016-04-11

Family

ID=55862186

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201508869U UA105855U (en) 2015-09-15 2015-09-15 METHOD OF TREATMENT OF REFERUSION DAMAGES OF THE HEART MUSCLE IN MYOCARDIAL INFARCTION

Country Status (1)

Country Link
UA (1) UA105855U (en)

Similar Documents

Publication Publication Date Title
EA201790398A1 (en) METHODS OF TREATING LIVER DISEASES
WO2016118951A3 (en) Heterocyclic itk inhibitors for treating inflammation and cancer
SG10201811185YA (en) Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viii
MX2017014584A (en) Heterocyclic inhibitors of erk1 and erk2 and their use in the treatment of cancer.
NI201600051A (en) COMBINATIONS OF HISTONE DESACETILASE INHIBITORS AND IMMUNOMODULATING DRUGS
BR112017018964A2 (en) use of plinabulin and methods to treat brain tumor
MX2018005071A (en) Treatment of small cell lung cancer with a parp inhibitor.
SA519401970B1 (en) Heterocyclic inhibitors of monocarboxylate transporter 4
MX2018007669A (en) Treatment of fabry disease in ert-naãve and ert-experienced patients.
MX2017005861A (en) Methods to target transcriptional control at super-enhancer regions.
NZ726695A (en) Gls1 inhibitors for treating disease
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
WO2016004413A3 (en) Gls1 inhibitors for treating disease
EA201790563A1 (en) APPLICATION OF WOODLIZUMAB FOR THE TREATMENT OF EOSINOPHIL ASTHMA WITH A DEGREE OF DIFFERENCE TO HEAVY
WO2016105516A8 (en) Methods of using smad7 antisense oligonucleotides
EP3590338A3 (en) Medical treatments based on anamorelin
TW201613639A (en) Methods for treating cardiovascular diseases
EA202193276A1 (en) METHODS FOR THE TREATMENT OF CHOLANGIOCARCINOMA
WO2017011356A3 (en) Mcj inhibitors for use in treating drug-induced diseases and conditions
MY186840A (en) Method for treating psoriasis patient which received anti-tnf-alpha antibody therapy
EA201650085A1 (en) METHOD OF TREATMENT OF TUMOR DISEASES AND METHOD OF SELECTIVE INHIBITION OF GROWTH OF TUMOR CELLS WITH THE HELP OF CHINOXALIN-1,4-DIOXIDE DERIVATIVE
SG10201809673RA (en) Treatment of androgen deprivation therapy associated symptoms
UA105855U (en) METHOD OF TREATMENT OF REFERUSION DAMAGES OF THE HEART MUSCLE IN MYOCARDIAL INFARCTION
RU2013130449A (en) METHOD FOR COMBINED TREATMENT OF RECTAL GUT CANCER
MY194135A (en) Treatment and diagnosis of inflammatory disorders